PAS
HALO icon

Park Avenue Securities’s Halozyme HALO Stock Holding History

Park Avenue Securities’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$790K Sell
10,089
-282
-3% -$19.2K ﹤0.01% 1069
2026
Q1 		$670K Buy
+10,371
New +$731K 0.01% 980
2025
Q4 		– Sell
-10,844
Closed -$795K – 1589
2025
Q3 		$795K Sell
10,844
-1,115
-9% -$74.1K 0.01% 973
2025
Q2 		$622K Sell
11,959
-1,837
-13% -$105K 0.01% 964
2025
Q1 		$880K Buy
13,796
+1,357
+11% +$78.8K 0.01% 666
2024
Q4 		$595K Buy
12,439
+801
+7% +$41.1K 0.01% 994
2024
Q3 		$666K Buy
11,638
+2,343
+25% +$134K 0.01% 859
2024
Q2 		$487K Buy
9,295
+1,001
+12% +$43.9K 0.01% 986
2024
Q1 		$337K Buy
8,294
+1,225
+17% +$45.9K ﹤0.01% 1132
2023
Q4 		$261K Sell
7,069
-594
-8% -$22.4K ﹤0.01% 1179
2023
Q3 		$293K Buy
+7,663
New +$314K ﹤0.01% 1060
2023
Q1 		– Sell
-7,668
Closed -$436K – 897
2022
Q4 		$436K Buy
7,668
+1,077
+16% +$55.1K 0.01% 829
2022
Q3 		$261K Buy
+6,591
New +$291K 0.01% 966

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Park Avenue Securities's HALO Position: Q2 2026 in Review

Park Avenue Securities reduced its Halozyme (HALO) stake by 2.7% in Q2 2026, selling an estimated $19.2K and leaving 10,089 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

Park Avenue Securities first reported a position in HALO in Q3 2022 and has held it in 13 quarters since. The position peaked at $880K in Q1 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Park Avenue Securities held 10,089 shares of Halozyme worth $790K as of Q2 2026.
  • Park Avenue Securities sold 282 Halozyme shares in Q2 2026, an estimated $19.2K.
  • Halozyme made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1069 holding.
  • Park Avenue Securities first reported a position in Halozyme in Q3 2022 and has held it in 13 quarters since.
  • Park Avenue Securities's Halozyme position peaked at $880K in Q1 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.